glp 1 antagonist exendin Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway It has also been used as a glucagon GLP1 Receptor Agonists—Effects beyond Obesity

benefits of incretin-based therapy (GLP-1, GIP)

It can emulsify and decompose fats and oils, improve blood circulation, remove peroxides, lower cholesterol and neutral fat content in blood, reduce the retention time of fats in the inner wall of blood vessels, promote the dissipation of atherosclerotic plaques, and prevent the intima thickening caused by cholesterol

Due to the anti-inflammatory properties of GHK-Cu, researchers tested how the compound would affect acute lung injury and lung damaged due to COPD

We deliver it back at concentrations designed to produce visibly firmer, smoother, more refined-looking skin